Thomas Buettner

Copper-64-diacetyl-bis( <i>N</i> ⁴ -methylthiosemicarbazone): An agent for radiotherapy

Jason S. Lewis, Richard Laforest, Thomas Buettner et al. · Proceedings of the National Academy of Sciences · 2001 · 214 citations · Full text

Medicine, Oncology, Pharmacology +14

Conjugation of Monoclonal Antibodies with TETA Using Activated Esters: Biological Comparison of ⁶⁴ Cu-TETA-1A3 with ⁶⁴ Cu-BAT-2IT-1A3

Michael R. Lewis, C. Andrew Boswell, Richard Laforest et al. · Cancer Biotherapy and Radiopharmaceuticals · 2001 · 44 citations

Pharmacy, Immunology, Oncology +17

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger et al. · PLoS Pathogens · 2021 · 42 citations · Full text

Medicine, Immunology, Pathology +15

CT contrast enhancement on brain scans and blood-CSF barrier disturbances in cerebral ischemic infarction.

C. Hornig, O. Busse, Thomas Buettner et al. · Stroke · 1985 · 40 citations

Medicine, Neurology, Radiology +17

Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.

Jason S. Lewis, Judith M. Connett, Joel R. Garbow et al. · PubMed · 2002 · 40 citations

Medicine, Oncology, Surgery +15